arrow_back Back to App

Glioblastoma Awareness Day: Supporting Research and Patients

The U.S. Senate designated July 21 as Glioblastoma Awareness Day to raise public awareness of this aggressive disease, support research for new treatments, and honor patients and their families. Citizens can expect increased attention to the needs of those affected by glioblastoma and potentially faster development of therapies.
Key points
Designation of July 21 as Glioblastoma Awareness Day to increase public awareness of the disease.
Encouragement of increased investment in glioblastoma research, including through the Glioblastoma Therapeutics Network.
Expression of support for patients, their families, and caregivers battling brain tumors.
article Official text account_balance Process page
Adopted
Citizen Poll
No votes cast
Additional Information
Print number: 117_SRES_210
Sponsor: Sen. Graham, Lindsey [R-SC]
Process start date: 2021-05-12
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

A resolution designating July 21, 2021, as "Glioblastoma Awareness Day".

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_SRES_210.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2021-05-12.

What are the main provisions?

Key points include:

  • Designation of July 21 as Glioblastoma Awareness Day to increase public awareness of the disease.
  • Encouragement of increased investment in glioblastoma research, including through the Glioblastoma Therapeutics Network.
  • Expression of support for patients, their families, and caregivers battling brain tumors.
What is the specific legal status?

The current status is Adopted.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Graham, Lindsey [R-SC].

What is the latest detailed status?

The latest detailed status is: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S2496; text: CR S2492)

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

CATEGORIES

Health